Skip to main content
Rural Health Information Hub

Rural Health
Resources by Topic: Prescription drug misuse

The University of Arizona Center for Rural Health Annual Report FY 2023-2024
Highlights the Center for Rural Health's accomplishments, and describes challenges and opportunities for improving the health of rural Arizonans in the upcoming year. Discusses the State Office of Rural Health, Arizona Health Improvement Plan (AzHIP), Arizona Rural Hospital Flexibility program (AzFLEX), Arizona Small Rural Hospital Improvement Program (AzSHIP), and other programs.
Date: 2024
Type: Document
Sponsoring organization: Arizona Center for Rural Health
view details
Primary Care Professionals' Perspectives on Tailoring Buprenorphine Training for Rural Practice
Interviewed 23 rural Ohio primary care professionals to identify barriers to prescribing buprenorphine for opioid use disorder treatment. Discusses the need for training addressing rural-specific barriers, limited patient access to required social supports, workforce, and stigma. Offers recommendations based on findings.
Author(s): Cheyenne Fenstemaker, Elizabeth A. Abrams, Benjamin Obringer, et al.
Citation: Journal of Rural Health, 2024
Date: 2024
Type: Document
view details
Defining and Evaluating In-Home Drug Disposal Systems for Opioid Analgesics: Proceedings of a Workshop
Offers summary of a June 2023 workshop to analyze in-home drug disposal systems with focus on unused opioid analgesics. Discusses the life cycle of prescribed opioids, characteristics of in-home disposal systems, implementation and equity concerns, legal concerns, environmental impacts, and real-world settings. Includes discussions of tribal and rural-specific challenges and benefits.
Additional links: Read Online
Author(s): Board on Health Sciences Policy
Date: 2024
Type: Document
Sponsoring organization: Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine
view details
Effectiveness of Syringe Services Programs
Presents a literature review of the studies evaluating SSP interventions across the country. Report aims to evaluate the overall efficacy of SSPs at reducing the transmission of HIV/HCV. Four of the 100 studies were conducted in completely rural settings, and 5 were conducted in both rural and urban settings. Makes recommendations for VA policy makers.
Additional links: Appendices, Executive Summary
Author(s): Katherine M. Mackey, Erin H. Beech, Beth E. Williams, et al.
Date: 12/2023
Type: Document
Sponsoring organization: VA Health Services Research & Development Service
view details
Changes in Perceptions of First Responders after Witnessing a Drug Overdose: Individual and Contextual Variations among People Who Use Opioids in West Virginia
Evaluates changes in attitude toward first responders among people who witnessed an overdose and stayed until first responders arrived. Utilizes interview data from 50 nonmedical users of prescription opioids from 3 rural Appalachian West Virginia counties. Identifies personal and contextual factors associated with changed perceptions of first responders.
Author(s): Kathleen L. Egan, Kelly Gurka, Alexandria Macmadu, Herb Linn
Citation: Journal of Appalachian Health, 5(3), 22-37
Date: 12/2023
Type: Document
view details
Disparities in Mortality Between Appalachian and Non-Appalachian Regions of Kentucky
Compares all-cause, drug-related, and opioid-related mortality in Kentucky, with breakdowns by metropolitan/nonmetropolitan and Appalachian/non-Appalachian counties. Utilizes 2000-2019 CDC WONDER mortality data. Identifies mortality trends, and discusses related demographic, geographic, and socioeconomic factors.
Author(s): Sonali S. Salunkhe, Sahal Alzahrani, Beatrice Ugiliweneza
Citation: Journal of Appalachian Health, 5(3), 38-52
Date: 12/2023
Type: Document
view details
Differences in Buprenorphine Prescribing Readiness Among Primary Care Professionals With and Without X-Waiver Training in the US
Examines readiness of primary care providers (PCPs) to prescribe buprenorphine to patients with opioid use disorder (OUD). Analyzes PCP knowledge of and confidence in buprenorphine, attitudes toward patients with OUD, and stress and/or empathy toward patients with OUD. Utilizes survey data from 403 PCPs in Ohio and discusses the challenges of addressing OUD in rural contexts.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, et al.
Citation: Harm Reduction Journal, 20, 180
Date: 12/2023
Type: Document
view details
High-Risk Individuals and Naloxone Use: Implications for THN Programs in Rural Appalachian Communities
Presents thematic analysis of factors influencing opioid overdose and naloxone use from interviews with 16 people who use opioid drugs in 4 rural, Appalachian Pennsylvania counties. Identifies opioid overdose risk factors, including substance use habits, as well as factors facilitating or preventing effective naloxone interventions. Covers naloxone access and knowledge, experiences, attitudes toward first responders, and disconnects between naloxone intervention and opioid dependence treatment.
Author(s): Victor Garcia, Lisa McCann, Erick Lauber, et al.
Citation: Journal of Appalachian Health, 5(3), 9-21
Date: 12/2023
Type: Document
view details
Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study
Highlights a study on the efficacy of telehealth-based treatment of opioid use disorder (OUD) for rural populations. Draws patient data from 2020-2022 across 14 states and breaks down data by patient characteristics, such as insurance status, education, and rurality, among other measures. Explores retention in care and adherence over a 6 month treatment period.
Author(s): Marlene C. Lira, Cynthia Jimes, M. Justin Coffey
Citation: Telemedicine and e-Health, 29(12), 1890-1896
Date: 12/2023
Type: Document
view details
Oversight Hearing titled, "Fentanyl in Native Communities: Federal Perspectives on Addressing the Growing Crisis"
Recording of a Congressional hearing addressing fentanyl among Native communities. Includes testimony from federal officials discussing previous efforts and future priorities for solving the opioid crisis. Subtitles available in the video player.
Additional links: Adam W. Cohen Testimony, Glen Melville Testimony, The Honorable Roselyn Tso Testimony, The Honorable Vanessa Waldref Testimony
Date: 12/2023
Type: Video/Multimedia
Sponsoring organization: Senate Committee on Indian Affairs
view details